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Binding constantCell-penetrating peptides (CPPs) provide a promising approach for enhancing intracellular delivery of thera-
peutic biomacromolecules by increasing transport through membrane barriers. Here, proteolytically stable
cell-penetrating peptidomimetics with α-peptide/β-peptoid backbone were studied to evaluate the effect
of α-chirality in the β-peptoid residues and the presence of guanidinium groups in the α-amino acid residues
on membrane interaction. The molecular properties of the peptidomimetics in solution (surface and intramo-
lecular hydrogen bonding, aqueous diffusion rate and molecular size) were studied along with their adsorp-
tion to lipid bilayers, cellular uptake, and toxicity. The surface hydrogen bonding ability of the
peptidomimetics reﬂected their adsorbed amounts onto lipid bilayers as well as with their cellular uptake,
indicating the importance of hydrogen bonding for their membrane interaction and cellular uptake.
Ellipsometry studies further demonstrated that the presence of chiral centers in the β-peptoid residues pro-
motes a higher adsorption to anionic lipid bilayers, whereas circular dichroism results showed that
α-chirality inﬂuences their overall mean residue ellipticity. The presence of guanidinium groups and
α-chiral β-peptoid residues was also found to have a signiﬁcant positive effect on uptake in living cells.
Together, the ﬁndings provide an improved understanding on the behavior of cell-penetrating
peptidomimetics in the presence of lipid bilayers and live cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The use of hydrophilic biomacromolecular therapeutics is generally
hindered by their poor permeation across the lipid bilayer of the plasma
membrane. Consequently, cell-penetrating peptides (CPPs) with a po-
tential to dramatically increase cellular uptake of biomacromolecular
drugs have attracted considerable interest during the past two decades.
The identiﬁcation of novel CPP candidates has traditionally involved ex-
tensive screening of peptide sequence libraries by studies of cellular up-
take and cargo delivery capability. Their cellular uptake mechanism(s)
as well as intracellular trafﬁcking have mostly been investigated by
the selective inhibition of uptake pathways and tracking of ﬂuorescent
cargos [1–5]. However, no consensus has been reached regarding a sin-
gle unifying mechanism as the preferred route of uptake. Instead it is+45 35 33 60 01.
l rights reserved.becoming increasingly evident that uptake pathways vary depending
on the properties of both the carrier and the delivered cargo, as well
as on the speciﬁc biological system studied [6–8].
Irrespective of the internalization mechanism, however, the initial
interaction of carrier peptide or peptidomimetic with the membrane
is a prerequisite for the subsequent membrane translocation process
[9–11]. Previous studies have demonstrated that the guanidinium
side chains of arginine, present in many cationic peptidic carriers,
play a crucial role for CPP uptake into cells. This is believed to be
due to the delocalized cationic charge enabling guanidinium groups
transiently to contribute with bidentate hydrogen bonding to cell
surface hydrogen bond acceptors [12–14].
Additionally, the effect of chirality on CPP uptake was previously
investigated by approaches such as comparison of all-L- and all-D-
forms of the same peptide sequence. Uptake was observed for the
D-peptide and a retro-inverso analog of penetratin, suggesting that
the cellular uptake of CPPs is a chirality-independent process
[15,16]. This hypothesis is also supported by more recent studies of
polyarginines and Tat peptide analogs [17,18]. Wender et al. reported
Fig. 1. Chemical structures of the peptidomimetics used in the current study.
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than all-L-Tat49–57, and this suggested that the improved cellular up-
take is likely due to an increased stability towards proteolysis [13].
The higher uptake efﬁciency of D-Tat and D-polyarginines was also
proposed to be a result of increased proteolytic stability [18,19]. How-
ever, it has also recently become evident that the effect of chirality
varies among different cell lines. A clear chirality-dependence in the
uptake of arginine-containing CPPs (e.g. R9 and penetratin) in MC57
ﬁbrosarcoma and HeLa cells was observed, but not in Jurkat T leuke-
mia cells [20]. To our knowledge, no clear consensus on how chirality
inﬂuences cellular uptake of CPPs has been reached yet.
In addition to membrane interaction, the proteolytic stability of
CPPs is crucial for their in vitro and in vivo applications, because optimal
metabolic stability is required for reaching improved bioavailability
of associated cargoes [21–24]. Previously, a series of proteolytically
stable guanidinylated α-peptide/β-peptoid chimeras conjugated to
carboxyﬂuorescein (CF) were shown to be taken up by cells four
times more efﬁciently than CF-labeled Tat47–57 [25]. The present
study provides additional insight into mechanistic details related
to the molecular structure of selected peptidomimetics with different
structural characteristics. Thus, peptidomimetics based on the α-
peptide/β-peptoid hybrid backbone architecture were investigated to
elucidate the inﬂuence of hydrogen bonding of guanidinium side
chains and of α-chirality in the β-peptoid residues on their membrane
interaction and cellular uptake. The molecular properties of the
peptidomimetics in solution, their structural changes upon interaction
with lipid membranes, and the quantiﬁcation of the adsorbed amounts
on anionic lipid bilayers were assessed along with their cellular uptake
and cytotoxicity properties.
2. Materials and methods
2.1. Materials
Amino acids and coupling reagents were obtained from IrisBiotech
(Marjtredwitz, Germany). Rink amide resin for the solid-phase syn-
thesis of peptidomimetics was provided by Sigma-Aldrich Chemie
(Steinheim, Germany). Ac-(Arg)8-NH2 (R8) and N-terminally car-
boxyﬂuorescein (CF)‐labeled CF-(Arg)8-NH2 (CF-R8) were purchased
from GenScript (Piscataway, NJ, USA) and were all >98% purity as
veriﬁed by HPLC and mass spectrometry. Palmitoyl-oleoyl phosphati-
dylcholine (POPC) and palmitoyl-oleoyl phosphatidylglycerol (sodi-
um salt) (POPG) were both from Avanti Polar Lipids (Alabaster, AL,
USA) (>98% purity). HEPES buffer was from AppliChem (Darmstadt,
Germany), Hanks Balanced Salt Solution (HBSS) was from Gibco
(Paisley, UK), 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-phenyl)-2-
(4-sulphophenyl)-2H-tetrazolium (MTS) was from Promega (Madison,
WI, USA), and phenazine methosulphate (PMS) was from Sigma (St.
Louis, MO, USA). All other chemicals were of analytical grade.
2.2. Synthesis of peptidomimetics
Non-labeled α-peptide/β-peptoid peptidomimetics and CF-
labeled compounds (1–6; Fig. 1) were prepared and characterized
as previously reported [26,27].
2.3. Molecular simulation
Four compounds comprising three α-peptide/β-peptoid pepti-
domimetics (1, 3, and 5), as well as the control peptide R8, were selected
for molecular simulations. Each compound consists of approximately
200–300 atoms, and the details about simulation model construction
and optimization are described below. The compounds were solvated
withwater to obtain their aqueous structures tomimic conditions similar
to the bulk aqueous phase with the TIP3P water model. As a result, each
molecular system comprises more than 10,000 atoms after adding 3500explicit water molecules. Brieﬂy, molecular simulation methods can
roughly be divided into two categories: quantum mechanics (QM) and
molecular mechanics or dynamics (MM/MD) based on an empirical
force ﬁeld. QM calculations usually give more accurate results than MM/
MD calculations, but are computationally demanding, especially for rela-
tively large systems like peptide and peptidomimetic structures. On the
contrary, MM/MD calculations using an empirical force ﬁeld are much
faster, but are strongly inﬂuenced by the accuracy of the force ﬁeld.
Both QM and MM/MD calculations were used in this study. QM calcula-
tions were applied to generate force ﬁeld parameters, which were used
in further MM/MD calculations for long-time simulations of the bio-
macromolecules in solution. Thus, QM calculations were performed
using the Gaussian03 program [28] to develop force ﬁeld parameters for
the studied peptidomimetics. The steps for deriving the forceﬁeld param-
eters from theQM calculations are as follows: (i) themoleculeswere built
in Gaussian View, (ii) the geometry of each of the molecules was opti-
mized, and (iii) the electrostatic potential (ESP) derived charges were
ﬁtted to reproduce themolecular electrostatic potential, which is a mo-
lecular property directly derived from the QM self-consist ﬁeld (SCF)
calculation. ESP charges are known to optimally handle intermolecular
properties, which are expected to be critical in our study.
Subsequently, several programs in Amber version 10 [29–31] were
used to generate the peptidomimetic structures. First, the output
from Gaussian calculations was analyzed with the antechamber pro-
gram to obtain force ﬁeld parameters. The program prepgen was
also used to generate all the structure units including either
N-terminal or C-terminal end units. Based on these structure units,
the peptide and peptidomimetics were constructed with the program
tleap [30].
After the peptide and peptidomimetics were built, water mole-
cules were added to solvate the molecules with a tool called Genbox
from Gromacs, after which the systems were optimized by energy
minimization with MM calculations. Further, MD calculations were
carried out at a temperature of 310 K (37 °C) for 5 ns. The NVT (Num-
ber, Volume, Temperature) ensemble [32] was used with a time step
of 1 fs thus implementing a constant number of particles (N) and
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ble is a statistical ensemble representing a probability distribution of
microscopic states of the system. Based on this, the hydrogen bond
number (both surface and intramolecular), the mean square displace-
ment (MSD), as well as the radius of gyration (Rg) were calculated. All
the MM and MD calculations and analyses were performed using
Gromacs 4.5.4 [32]. After 2.5 ns simulation, the total energy and gyra-
tion radius for each system became stable, indicating that the system
has reached equilibrium. The simulation time of 2.5 ns should be suf-
ﬁciently long to erase the effect of the starting conﬁgurations. Ewald
summation was used to calculate the electrostatic interactions and
the relative strength of the electrostatic interaction at the cutoff of
1.0×10−5.
The number of hydrogen bonds was determined based on cut-off
values for the angle of acceptor–donor–hydrogen bonds and the dis-
tance between hydrogen–acceptor. The OH and NH groups were reg-
arded as donors, O always as an acceptor, and a hydrogen bond was
counted if the length between a donor and an acceptor (bond length)
was less than 3.5 Å and the bond angle was smaller than 30°.
The Rg was used to characterize the size of the molecules in solu-
tion and was calculated as follows;
Rg ¼
∑Ni krijj2mi
∑Ni mi
 !1
2
ð1Þ
where mi is the mass of atom i, N is the number of atoms in the mol-
ecule, and ri is the position of atom i with respect to the center of
mass of the molecule.
The MSD was used to characterize the dynamic behavior of the
molecules as a function of correlation time and was calculated
according to Eq. (2).
MSD Δtð Þ ¼∑Ni ri t þ Δtð Þ−ri tð Þj j2 ð2Þ
where ri(t) is the position of the atom i at time t, N is the number of
atoms of a molecule, Δt is the correlation time and the right hand
side of the equation represents an average on the time steps.
The slope of the MSD or the so-called diffusion constant (D) can be
calculated according to Eq. (3):
D ¼ lim
Δt→∞
1
6t
MSD Δtð Þ: ð3Þ
2.4. Preparation of liposomes
Anionic, unilamellar liposomes (POPC:POPG, 80:20, molar ratio)
for the ellipsometry, circular dichroism (CD), and isothermal titration
calorimetry (ITC) studies were prepared by the thin ﬁlm method as
described previously [25,33]. Brieﬂy, in order to obtain small
unilamellar vesicles (SUVs) for deposition onto supported silica sur-
faces for the ellipsometry studies, dry lipid ﬁlms were ﬁrst formed
overnight in round-bottomed ﬂasks under vacuum, after which the
lipid ﬁlms were hydrated in a 10 mM HEPES buffer (pH 7.4) to a
ﬁnal lipid concentration of 6.5 mM. The large multilamellar vesicles
(LMVs) formed were subjected to eight freeze–thaw cycles and then
extruded 31 times through 30 nmpolycarbonatemembranes (Whatman,
Kent, UK) using a LipoFast Basic extruder (Avestin,Mannheim,Germany).
For the CD measurements, the vesicles were extruded 10 times through
50 nm pore size polycarbonate membranes (Whatman, Kent, UK)
obtaining a ﬁnal lipid concentration of approximately 4 mM. For the ITC
studies, the lipid ﬁlms were hydrated for 1 h with vigorous agitation
every tenth minute at room temperature with a buffer containing
10 mM HEPES and 150 mM KCl (pH 7.4) to give a lipid concentration of
20 mM. Upon annealing for 1 h, large multilamellar vesicles (LMVs)
were extruded (Lipex™ Biomembranes extruder, Vancouver, BC, Canada)10 times through two stacked polycarbonate membrane ﬁlters with
100 nm pore size (Whatman, Herlev, Denmark). For all batches used for
ITC, the expected vesicle size and polydispersity index (PDI)were veriﬁed
by photon correlation spectroscopy. The surface charge of the particles
was estimated by analysis of the zeta-potential (Laser-Doppler Electro-
phoresis). The measurements were performed at 25 °C using a Zetasizer
Nano ZS (Malvern, Worcestershire, UK) equipped with a 633 nm laser
and 173° detection optics. Malvern DTS v.6.20 software (Malvern,
Worcestershire, UK) was used for data acquisition and analysis. For vis-
cosity and refractive index, the values of pure water were used.
2.5. Ellipsometry
The adsorption of the peptides/peptidomimetics to supported
lipid bilayers was studied by null ellipsometry using an Optrel Multi-
skop (Optrel, Kleinmachnow, Germany) equipped with a 100 mW
argon laser (532 nm) as described previously [34]. The measurements
were carried out at an angle of incidence of 67.52° in a 5 mL cuvette
under stirring. The adsorption of lipid as well as peptide and
peptidomimetics was monitored by measuring the changes in ampli-
tude and phase of light reﬂected at the adsorbing surface. The ﬁnal
adsorbed amount (Γ) was calculated using a refractive index incre-
ment (dn/dc) of 0.154 cm3/g [35]. Silica surfaces (Okmetic, Vantaa,
Finland) for ellipsometry were prepared from polished silicon slides,
which were oxidized to a 30 nm thick oxide layer [36]. Poly-L-lysine
(Mw 167.8 kDa, Sigma‐Aldrich, Seelze, Germany) was pre-adsorbed
to the surfaces prior to lipid deposition to avoid peptide/
peptidomimetic adsorption directly onto the silica substrate through
any lipid bilayer defects. The supported anionic lipid bilayer was
formed by the liposome adsorption method [37] using 30 nm POPC:
POPG (80:20 molar ratio) liposomes. After lipid bilayer formation
and subsequent rinsing to remove residual liposomes, peptide or pep-
tidomimetic was added to obtain an initial total concentration of
0.01 μM in the cuvette. This initial injection was followed by three
subsequent peptide additions to achieve the ﬁnal concentrations of
0.1, 0.5, and 1 μM. In all cases, the adsorption was monitored for
around 1 h or longer until adsorption had stabilized. All measure-
ments were performed at least in duplicates.
2.6. Isothermal titration calorimetry
Thermodynamic analysis of the peptidomimetic adsorption to
POPC:POPG liposomes was performed using a Nano ITC (TA Instru-
ments, New Castle, USA) as previously described [33]. Brieﬂy, the
reaction cell (Vcell=1 mL), ﬁlled with the peptidomimetic dissolved
in buffer (10 mM HEPES and 150 mM KCl, pH 7.4), was titrated
10 μL at a time at 5 min intervals into liposome dispersions under
constant stirring at 300 rpm at 37 °C. The titrant peptidomimetic con-
centration was determined spectrophotometrically using an extinc-
tion coefﬁcient of 1182 l/mol·cm, and the ﬁnal concentration in the
reaction cell ranged from 19 to 43 μM. For reference purposes, the li-
posome dispersion was injected into buffer showing constant non-
zero heats. Titrations were performed in duplicate and all solutions
were degassed prior to use. The data were processed by the software
(Nano ITC Run, TA instruments) provided with the Nano-ITC instru-
ment to obtain the injection heats.
2.7. Circular dichroism spectroscopy
The CD spectra of the peptidomimetics in PBS buffer or mixed with
a POPC:POPG (80:20 molar ratio) liposome suspension in the same
buffer were measured in the range of 200–250 nm with an Olis
DSM 10 Spectrophotometer (OLIS, Bogart, GA, USA) using 1 mm qua-
rtz cuvettes. The instrument was routinely calibrated for wavelength
and optical rotation magnitude with (1S)-(+)-10-Camphorsulfonic
acid standard solution (Sigma-Aldrich, St. Louis, MO, USA) using a
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a peptidomimetic concentration of 20 μM and a lipid concentration of
2 mM, i.e., at detectable peptidomimetic concentrations and a ﬁxed
lipid:peptidomimetic molar ratio of 100:1. All spectra were background-
corrected, smoothed, and transformed into mean residue ellipticity [θ].
Data were analyzed using the Globalworks software (OLIS, Bogart, GA,
USA) incorporating a digital ﬁltering function [38]. Each spectrum is an
average of at least 5 scans.
2.8. Cell culture
HeLa WT cells, Caco-2 cells and Calu-3 cells (ATCC, Manassas, VA,
USA) were cultured at 37 °C in an atmosphere of 5% CO2/95% O2 in es-
sential medium supplemented with 10% (v/v) fetal bovine serum (FBS)
from Fisher Scientiﬁc (Hampton, NH, USA), 100 U/mL penicillin and
100 μg/mL streptomycin (both from Sigma-Aldrich, St. Louis, MO,
USA). To obtain the complete medium used for culturing the cell
lines, Eagle's Minimum Essential Medium (EMEM) used for the HeLa
cells was further supplemented with 0.1 mM non-essential amino
acids (NEAA, Sigma-Aldrich, St. Louis, MO, USA) and 1 mM sodium py-
ruvate (Invitrogen, Carlsbad, CA, USA), Dulbecco's Modiﬁed Essential
Medium (DMEM) used for Caco-2 cells was supplemented with
0.1 mM NEAA and 50 μg/mL gentamicin and for Calu-3 culturing, the
DMEM was only further supplemented with 50 μg/mL gentamicin.
2.9. Flow cytometry
HeLa cells (1×105 cells per well) were seeded in 24-well tissue
culture plates (surface area 1.9 cm2/well) in 1 mL complete medium
(containing 10% (v/v) FBS) and were then incubated for 24 h. The
cells were washed with PBS and subsequently incubated with pre-
mixed samples containing a total peptide or peptidomimetic concen-
tration of 1 μM or 10 μM in complete medium with FBS for 10 min or
60 min at 37 °C. Afterwards, the cells were washed with PBS and
trypsinized, and 1 mL ice-cold PBS containing 10% (v/v) FBS was
added to each well. The suspended cells were transferred to tubes,
centrifuged (1076×g, 4 °C, 5 min) and re-suspended twice, after
which the cells resuspended in ice-cold PBS containing 10% (v/v)
FBS and 1 μg/mL propidium iodide (PI) (Invitrogen, Carlsbad, CA,
USA) were analyzed. The cells were kept on ice prior to analysis.
The mean ﬂuorescence was measured with a FACScan ﬂow cytometer
(Becton Dickinson, Mountain View, CA, USA) equipped with a 488 nm
argon ion laser and 530/30 nm bandpass ﬁlter for detection. Dead
cells were excluded based on PI staining, and cells exposed to com-
plete mediumwere used as negative controls (n=3). Statistically sig-
niﬁcant differences were assessed by an analysis of variance (ANOVA)
at a 0.05 signiﬁcance level, followed by Tukey's post test.
2.10. Cell viability
The effect of CF-labeled α-peptide/β-peptoid peptidomimetics
and CF-R8 on cellular viability was tested by the MTS/PMS assay, es-
sentially as described previously [39]. Three different cell lines,
HeLa, Caco-2 and Calu-3, were cultured in 96-well plates at 37 °C
for approximately 24 h in culturing medium until 80–100% con-
ﬂuency. The seeding densities of HeLa, Caco-2 and Calu-3 cells were
9,000, 90,000 and 40,000 cells/well, respectively. The cells were
washed with HBSS, and then exposed to solutions of CF-labeled
peptidomimetics or CF-R8 (n=3) dissolved in complete medium at
different concentrations (2 to 256 μM) for 1 h at 37 °C. Immediately
after incubation, the cells were washed with HBSS, and 100 μL of
freshly prepared MTS/PMS reagent in HBSS was added to each well
followed by incubation at 37 °C for 1 h. The dehydrogenase activity
was determined by measuring the amount of produced formazan,
which has a maximum absorption wavelength of 492 nm. Cells ex-
posed to complete medium were used as negative control, and cellsexposed to 0.2% (w/v) SDS as positive control. All values were back-
ground‐subtracted, and the results are presented as concentration–
response curves obtained after data ﬁtting by non-linear regression
with four variable parameters as described previously [40].
3. Results
In the present study, three structurally different types of
peptidomimetics with membrane-penetrating properties were in-
vestigated for membrane interaction using model lipid bilayers as
well as live cells, and the obtained results correlated well to molec-
ular simulations of the tested compounds. Both peptidomimetics 1
and 3 had guanidinium groups (Fig. 1), yet construct 3 had α-
chiral side chains due to the extra methyl groups in the β-peptoid
residues, resulting in a total of six additional chiral centers as com-
pared to construct 1. Structurally, 3 and 5 differ by the presence of
guanidinium groups in 3 and ammonium groups in 5, respectively.
3.1. Molecular simulations of peptidomimetics in solution revealed four
of their molecular properties
The molecular properties of the peptidomimetics and R8 in solu-
tion were calculated from the molecular simulations. Due to the arti-
ﬁcial backbone and side chain design of these α-peptide/β-peptoid
peptidomimetics, the information available on the structural and dy-
namical characteristics of this class of molecules is very limited. Cur-
rently, there are no conventional methods to measure dihedral angles
and determine secondary structures. Since there is no existing param-
eters available in the literature for MM/MD calculations of the
α-peptide/β-peptoid constructs either, a series of QM calculations
were utilized to generate a set of force ﬁeld parameters, which were
used in subsequent MM and MD calculations.
Snapshots of the molecular dynamics of compounds in solution
are presented in Fig. 2. The total number of hydrogen bonds between
each molecule and solvating water molecules was determined by
simulation (Fig. 3A). The order of the peptidomimetics based on de-
creasing number of hydrogen bonds with water (average in last
2.5 ns) is summarized as 3 (51.6)>1 (48.8)>5 (43.9), whereas the
number of intramolecular hydrogen bonds (Fig. 3B) resulted in the
order 1 (5.64)>3 (5.30) >>5 (2.53) (average in last 2.5 ns). The dy-
namic mobility of the molecules, represented by the slope in Fig. 3C
(MSD vs time), decreased in the order of 3 (473 Å2/ns)>5 (442 Å2/ns)
>>1 (314 Å2/ns). The order of the peptidomimetics based on their de-
creasing size in water (average Rg) was 3 (8.82 Å)>5 (8.28 Å)>1
(7.60 Å) (Fig. 3D). The parameters for the reference peptide R8 were as
follows: average number of hydrogen bonds with water; 49.3; number
of intramolecular hydrogen bonds; 0.26; dynamic mobility; 348 Å2/ns,
and Rg: 8.73 Å.
3.2. The presence of guanidinium and methyl groups in peptidomimetics
results in higher adsorption and binding to anionic lipid bilayers
To further elucidate the inﬂuence of different molecular properties
of peptidomimetics on their interaction with lipid membranes, the
amounts of 1, 3, 5 and R8 adsorbed onto supported anionic lipid
bilayers were monitored by ellipsometry. The respective pep-
tidomimetic/peptide concentrations were increased step-wise from
0.01 μM to 1 μM (Fig. 4). The presence of guanidinium groups in 3
resulted in a much higher adsorption than found for its ammonium-
substituted counterpart 5 due to the ability of the former to make
strong bidentate hydrogen bonds with various anions such as the
phosphate head groups of the membrane lipids [41]. When compar-
ing peptidomimetics 1 and 3, the presence of an extra methyl group
introducing α-chirality in the β-peptoid residues in 3 promotes a
higher adsorption onto the lipid bilayer.
Fig. 2. Snapshots of the molecular dynamics simulations of peptidomimetics 1, 3 and 5
and peptide R8 in solution. The snapshots correspond to a probe radius of 1.4 Å. The
coloring is depicted according to atom type: blue (nitrogen), red (oxygen), green (car-
bon) and white (hydrogen).
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of the adsorption process, ITC studies were performed. Data pres-
ented in Table 1 show that at physiological temperature the binding
enthalpies for 1 and 3 are similar and more favorable than for 5, yet
no signiﬁcant difference is observed regarding the overall binding en-
ergy, ΔG. The values obtained for 1 are comparable with previously
reported data [33]. Overall, the bound amount of 5 was signiﬁcantly
less than for the homoarginine-containing peptidomimetics.3.3. Anionic liposomes inﬂuence the folding of partially chiral
peptidomimetics to a higher extent as compared to fully chiral
peptidomimetics
Complementary to ellipsometry and ITC, CD studies were carried
out to elucidate the peptidomimetic structural features in the pres-
ence or absence of anionic lipid membranes (Fig. 5).
The comparative circular dichroism studies of the three different
peptidomimetics (1, 3 and 5) in buffer clearly showed a higher degree
of ordered structure for the fully chiral oligomers 3 and 5, as com-
pared to the partially chiral oligomer 1 (Fig. 5). Previous studies
have shown that α-peptide/β-peptoid oligomers displaying achiral
β-peptoid residues exhibit a low degree of ordered structure in the
presence of overall neutral DPPC liposomes [42] as well as in an or-
ganic medium [26], as compared to the fully chiral analogs, while
the minimum of the ellipticity is almost constant (at ~220 nm). Inter-
estingly, comparison of the folding propensity of peptidomimetics 1,
3 and 5 in the presence of anionic POPC:POPG liposomes in the pre-
sent study revealed a pronounced shift of the minimum for the
mean residue ellipticity observed for partially chiral peptidomimetic
1, whereas no signiﬁcant change was seen for the fully chiral 3 and
5 (Fig. 5). Altogether, this suggests that this type of peptidomimetics
interacts differently with neutral and anionic liposomes.
3.4. The presence of guanidinium and methyl groups strongly inﬂuences
cellular uptake, potentially as a result of α-chirality in the β-peptoid
residue
To correlate the observations related to the interactions of
peptidomimetics with model lipid membranes with their uptake in
cells, cellular uptake studies were performed with CF-labeled
peptidomimetics using ﬂow cytometry. The overall order of uptake efﬁ-
ciency of the peptidomimetics was conserved at all conditions (Fig. 6).
Fully chiral homoarginine-based peptidomimetic 4 showed the highest
uptake efﬁciency in all experiments, while the partially chiral
homoarginine-based peptidomimetic 2 ranked second exhibiting com-
parable uptake within the same order of magnitude, whereas the
lysine-based 6 had a signiﬁcantly lower uptake in the same range as R8.
This is consistent with other studies also demonstrating that arginines
present in various CPPs play an important role for their intracellular
uptake [43–46]. The effects of incubation time (Fig. 6A and B) and com-
pound concentration (Fig. 6A and C) on the total uptakewere also clearly
demonstrated.When increasing the peptidomimetic concentration from
1 μM to 10 μM and keeping the incubation time at 60 min, the cellular
uptake increased drastically (approximately 30 times for 4). Similarly,
when the incubation time was increased from 10 to 60 min with a
ﬁxed concentration of 10 μM, increased cellular uptake was observed
for all compounds, but to a lesser extent (approximately 2 times higher
for 4).
3.5. Cell viability
The tolerance threshold of HeLa cells towards exposure to the
three CF-labeled peptidomimetics and CF-R8 (Fig. 7) was investigated
for proper assessment of the cellular uptake studies. Overall, concen-
trations of up to 10 μM of these compounds were well-tolerated in
the cells, but at higher concentrations, peptidomimetic 2 and 4
proved more toxic than 6. The same tendency was observed from
studies using proliferating Caco-2 and Calu-3 cells, yet it was evident
that the HeLa cells in general were more sensitive to the exposure and
that the estimated IC50 values varied with the cell line tested.
4. Discussion
The unnatural molecular designs of α-peptide/β-peptoid pepti-
domimetics were investigated for their membrane interaction and
Fig. 4. Adsorption of peptidomimetics (1, 3, and 5) and R8 to supported POPC:POPG
(80/20) bilayers in HEPES buffer containing 150 mM KCl. * refers to non-detectable
adsorption.
2665X. Jing et al. / Biochimica et Biophysica Acta 1818 (2012) 2660–2668cellular uptake as well as toxicity in the current study. Structural
characterization of the compounds by NMR has proved fruitless so
far because of signal overlap arising from the repetitive nature of
the homomeric constructs. Thus, information regarding the second-
ary structure of these unnatural oligomers is not available, which con-
stitutes a major obstacle to their further molecular understanding. To
facilitate correlation and comparison of observed membrane interac-
tions and cellular activities of this recently described class of
peptidomimetics, molecular simulation was employed to calculate
their molecular properties in solution e.g. size, dynamic mobility
and intramolecular hydrogen bonding and extramolecular hydrogen
bonding with water. When correlating the calculated molecular prop-
erties of the peptidomimetics with their membrane adsorption and
cellular uptake, it was observed that only the parameter of extra-
molecular hydrogen bonding with water (Fig. 3A) correlated positive-
ly with the observed levels of adsorption to membranes (Fig. 4) and
cellular uptake (Fig. 6). This indicates that the number of hydrogen
bonding sites on the peptidomimetics might be an important factor
for the interaction between the peptidomimetics and lipid mem-
branes as well as for their cellular uptake. Thus, the calculated degree
of hydrogen bonding with water reﬂects the measured adsorption
onto lipid membranes, suggesting the latter involves hydrogen bond-
ing with the lipid head groups. In particular, bidentate hydrogen
bonds formed between guanidinium-rich peptides and H-bond ac-
ceptors on the cell surface have previously been demonstrated to be
important for efﬁcient membrane interaction and cellular uptake
[41,47]. Furthermore, the ranking of the peptidomimetics based on
the intramolecular hydrogen bonding (Fig. 3B) corresponds to the
ranking based on their mean residue ellipticity obtained from the
CD studies (Fig. 5), suggesting that intramolecular hydrogen bonding
capacity might constitute a major structural determinant for folding
of the peptidomimetics. On the other hand, the MSD and Rg values
obtained from molecular simulations do not seem to be correlated
with membrane interaction or cellular uptake, suggesting that these
parameters might be functionally less important for membrane inter-
actions and cellular uptake, at least within the parameter range
investigated.
The adsorbed amounts of different peptidomimetics onto
supported anionic lipid bilayers as measured by ellipsometry showed
that the guanidinylated fully chiral peptidomimetic 3was adsorbed to
a substantially higher degree than the corresponding amino-
functionalized peptidomimetic 5. In addition, the adsorbed amount
of 3 was higher than the adsorbed amount of the partially chiralFig. 3. Time evolutions of (A) the number of hydrogen bonds with water, (B) the num-
ber of intramolecular hydrogen bonds, (C) MSD and (D) Rg of three peptidomimetics 1
(red), 3 (green), 5 (yellow) and R8 (black) from the MD simulations.
Table 1
Thermodynamic parameters for the adsorption of peptidomimetics to POPC:POPG lipo-
somes at 37 °C obtained by ﬁtting the ITC data. The values are presented per mol of
peptidomimetic. The experiments were performed in duplicate.
Peptidomimetic ΔH
(kJ/mol)
K
(μM−1)
n Bound POPGa ΔG
(kJ/mol)
−TΔS
(kJ/mol)
1 −22.2
−28.0
0.19
0.28
0.017
0.013
6
8
−31.4
−32.3
−9.2
−4.3
3 −26.1
−23.9
0.61
0.37
0.017
0.019
6
5
−34.3
−33.1
−8.3
−9.2
5 −17.9
−17.8
0.34
0.46
0.007
0.007
14
14
−32.9
−33.6
−14.9
−15.9
a Surface POPG per peptide, calculated as 0.1/n, as only 10 mol% of POPG is on the
outer surface and thus available for binding.
Fig. 6. Cellular uptake of peptidomimetics determined by ﬂow cytometry. HeLa-cells
were incubated with CF-labeled peptidomimetic 2, 4, 6 or CF-R8 at 37 °C: (A) at
10 μM for 60 min, (B) at 10 μM for 10 min, and (C) at 1 μM for 60 min. The mean ﬂuo-
rescence intensity data represent mean±standard deviation of three samples. Signiﬁ-
cant differences from CF-R8 are indicated: ***pb0.001.
2666 X. Jing et al. / Biochimica et Biophysica Acta 1818 (2012) 2660–2668analog 1. In the present study, hydrogen bonding, especially when
bidentate in nature, between peptidomimetics and lipid membranes,
appears to be the predominant interaction force for peptidomimetics
1 and 3. An overall positive charge is necessary, but not sufﬁcient for
efﬁcient adsorption and translocation as seen by the low adsorbed
amount and poor cellular uptake of 5 that carries lysine side chains
instead of homoarginine side chains. Both the basic lysines (pKa
~10.5), which contains one ammonium group, and the strongly
basic homoarginines with a pKa of ~12.5 may be considered fully pro-
tonated under physiological conditions, however, the homoarginine
residues also possess a delocalized positive charge in the guanidinium
group that enables formation of an ion pair [48] or even coordinated
bidentate hydrogen bonds [41] with anionic membrane constituents,
which promote its adsorption onto and subsequent translocation
through membranes. Also, it has been reported that increased hydro-
phobicity of a protein results in increased adsorption at hydrophobic
surfaces [49]. In our study, all peptidomimetics display similar hydro-
phobic side chains (benzyl or 1-phenylethyl) in the primary se-
quences. However, the presence of an extra methyl group
introducing the side chain α-chirality appears to result in a more fa-
vorable arrangement of the hydrophobic residues for membrane ad-
sorption, as peptidomimetic 3 is adsorbed to a higher extent than 1.
From the ITC experiments, the binding parameters of pepti-
domimetics 1 and 3 to POPC:POPG membranes are very similar. The
CD data indicate that the presence of anionic liposomes induces addi-
tional structure in peptidomimetic 1, but not in peptidomimetic 3,
thus indicating that the existence of secondary structure in the free
peptidomimetic has no importance for neither the bound amount
nor the enthalpy of binding. The Gibbs free energy of interaction of
peptidomimetic 3 was slightly higher than for 1, although the differ-
ence is minor and within the limits of the experimental error. AFig. 5. CD spectra of peptidomimetics in PBS buffer and in the presence of POPC:POPG
liposomes (lipo).comparison of the two homoarginine (hArg)-containing pepti-
domimetics 1 and 3 to the Lys-containing 5 compound shows that
this difference in composition is not important for the overall binding
energy, ΔG. The enthalpy of interaction is lower for peptidomimetic 5,
suggesting that the heat effect is associated with the presence of gua-
nidinium groups. However, since the overall charge of hArg (pKa
~12.5) and Lys (pKa ~10.5) at pH 7.4 may be considered identical,
the difference in ΔH values is not considered to be due to the electro-
static forces. The less favorable enthalpy of interaction of pep-
tidomimetic 5 is compensated by a more favorable entropy, which,
according to the CD data, is not caused by structural changes of pep-
tidomimetic 5 upon binding (Fig. 5). Therefore, it is suggested that
the more favorable entropy is associated with the effect of pep-
tidomimetic 5 on the lipid bilayer, rather than with the pep-
tidomimetic itself. Indeed, the ellipsometry data indicate that
peptidomimetic 5 does not affect the optical properties of the bilayer
to the same extent as the other two, thus suggesting that binding of
the Lys-containing ligand is more superﬁcial than the interaction of
hArg-containing peptidomimetics. In other words, hArg seems to
disturb the structure of the lipid bilayer to a higher extent thus
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Fig. 7. Effect of CF-labeled peptidomimetics and CF-R8 on the viability of HeLa (black
circle), Caco-2 (black triangle) and Calu-3 cells (white circle). The cell viability after ex-
posure for 1 h was determined by the MTS/PMS assay. The data is expressed as the
mean percentage viability relative to the control+/−SD (n=3).
2667X. Jing et al. / Biochimica et Biophysica Acta 1818 (2012) 2660–2668facilitating a closer interaction between the peptidomimetics and the
liposomes. Finally, the bound amount, n, is signiﬁcantly lower for
peptidomimetic 5 than for the other two peptidomimetics, explaining
an apparent absence of binding of oligomer 5, when measured by
ellipsometry (Fig. 4). Due to the low n, ellipsometry experiments on
this peptidomimetic must be performed at higher concentrations
than for oligomers 1 and 3.
The observation that the CD spectrum of 1 was noticeably altered
in the presence of anionic liposomes may be correlated to the absence
of the additional methyl branching in the β-peptoid residues of 1,
which obviously results in an increased molecular ﬂexibility of the
side chains. By contrast, the bulky methyl group positioned next to
the α side chain in 3 and 5 limits the rotational degrees of freedom
around the backbone resulting in a more rigid structure.
Uptake experiments with HeLa cells clearly showed the importance
of the guanidinium groups, as illustrated by the relatively high uptake
of the two homoarginine‐rich peptidomimetics 2 and 4 as compared
to the lysine-rich peptidomimetic 6 at all concentrations and incubation
times tested. The fully chiral 4was also taken up to a larger extent than
the partially chiral counterpart 2. Overall, the guanidinium-rich, fully
chiral peptidomimetic 4 was taken up most efﬁciently, and its uptake
level was signiﬁcantly higher than that of CF-R8 under all the tested con-
ditions. These comparative cellular uptake results of peptidomimetics
are consistent with the trend found for their adsorption on anionic
lipid bilayers by ellipsometry. Moreover, peptidomimetics 2 and 4
exhibited similar cytotoxicity as judged by the cell viability assay,
while the ammonium-functionalized 6 was less cytotoxic in all three
tested cell lines. At high concentrations, extensive accumulation of the
strongly interacting guanidinium-containing peptidomimetics 2 and 4
might eventually lower the cell viability possibly by destabilizing the
cell membranes. But overall, the effective concentrations of 2 and 4 are
two orders of magnitude lower than the highest concentrations used
in the viability assay and none of the concentrations tested in the uptake
experiments were shown to be cytotoxic. The ratio of relative uptake ef-
ﬁciency over cytotoxicity indicates the overall beneﬁt of compounds 2
and 4 as compared to 6 and R8.5. Conclusions
Molecular simulation of α-peptide/β-peptoid peptidomimetics in
solution led to different rankings of the studied compounds based
on four molecular properties comprising size, diffusion rate, and hy-
drogen bonding (both surface and intramolecular). The ranking of
the peptidomimetics based on surface hydrogen bonding capacity is
in agreement with their efﬁciency observed in adsorption studies
using model membranes and in cellular uptake experiments. Besides
the remarkable inﬂuence of hydrogen bonding ability of guanidinium
groups, the ellipsometry studies also clearly showed that the pres-
ence of a methyl group introducing α-chirality of the β-peptoid resi-
dues in the peptidomimetics resulted in higher adsorption onto an
anionic lipid bilayer. This may be explained not only by the presence
of chirality, but also by the additional methyl groups present. Howev-
er, further structural studies using CD showed that α-chirality inﬂu-
ences the overall mean residue ellipticity, and a clear shift of
minimum was observed only for the partially chiral compound 1
when interacting with anionic liposomes. The presence of gua-
nidinium groups promoted cellular uptake signiﬁcantly, but α-
chirality of the β-peptoid residues also has a positive inﬂuence on
the uptake. Increasing the peptidomimetic concentration induced a
more pronounced increase in the amount taken up than increasing
the incubation time, even at concentrations well tolerated by the
HeLa cells. The study demonstrates that thorough molecular under-
standing, membrane interaction and cellular activity proﬁling are im-
portant for the future design of cell-penetrating peptidomimetics.
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